Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation

Eirini Dimidi, Ausra Zdanaviciene, Stephanos Christodoulides, Shiva Taheri, Petra Louis, Peter I. Duncan, Nashmil Emami, Rafael Crabbé, C. Antonio De Castro, Peter Mclean, Gabriela E. Bergonzelli, Kevin Whelan, S. Mark Scott

Nutritional Sciences

Guys & St Thomas NHS Fdn Trust, Guy's & St Thomas' NHS Foundation Trust, Kings College Hospital, King's Health Partners, Kings Coll Hosp, Kings Hlth Partners Acad Hlth Sci Ctr, Dept Neuroradiol
Barts Hlth NHS Trust, Queen Mary University London, University of London, London Chest Hosp
Centre for Neuroscience & Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK; Sobell Department of Motor Neuroscience and Movement Disorders, University College London, Queen Square, London, UK.
University of Aberdeen
Department of Gastrointestinal Health; Nestlé Research; Lausanne Switzerland
Nestlé Research Center

Research output: Contribution to journal › Article › peer-review

55 Citations (Scopus)

662 Downloads (Pure)

Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation

Fingerprint

Medicine and Dentistry